Molecular indexing of internal sequences

    公开(公告)号:US11220685B2

    公开(公告)日:2022-01-11

    申请号:US16836750

    申请日:2020-03-31

    Inventor: Glenn Fu Eleen Shum

    Abstract: The present disclosure relates to compositions, methods and kits for labeling an internal sequence of a target nucleic acid molecule with molecular barcodes. In some embodiments, the methods comprise intramolecular circulation of a labeled target nucleic acid molecule. Further provided methods for generating sequencing libraries comprising overlapping fragments covering the full length of a target nucleic acid molecule, sequencing the libraries using the methods disclosed herein, and methods of analyzing sequencing results therefrom.

    Compositions and kits for molecular counting

    公开(公告)号:US10941396B2

    公开(公告)日:2021-03-09

    申请号:US14381488

    申请日:2013-02-27

    Abstract: Methods, kits and systems are disclosed for analyzing one or more molecules in a sample. Analyzing the one or more molecules may comprise quantitation of the one or more molecules. Individual molecules may quantitated by PCR, arrays, beads, emulsions, droplets, or sequencing. Quantitation of individual molecules may further comprise stochastic labeling of the one or more molecules with a plurality of oligonucleotide tags to produce one or more stochastically labeled molecules. The methods may further comprise amplifying, sequencing, detecting, and/or quantifying the stochastically labeled molecules. The molecules may be DNA, RNA and/or proteins.

    PRECISE DELIVERY OF COMPONENTS INTO FLUIDS
    44.
    发明申请

    公开(公告)号:US20200299672A1

    公开(公告)日:2020-09-24

    申请号:US16799464

    申请日:2020-02-24

    Abstract: Disclosed herein include systems, apparatuses, devices, and methods for introducing one or more components into a fluid. A first fluid and a second fluid can be co-injected into a fluidic channel of a flow cell. In some embodiments, the first fluid and a second fluid are immiscible (e.g. an aqueous buffer and a non-aqueous liquid). In some embodiments, the second fluid is less dense than the first fluid.

    WHOLE TRANSCRIPTOME ANALYSIS OF SINGLE CELLS USING RANDOM PRIMING

    公开(公告)号:US20200149037A1

    公开(公告)日:2020-05-14

    申请号:US16677012

    申请日:2019-11-07

    Inventor: Eleen Shum

    Abstract: Disclosed herein include systems, methods, compositions, and kits for whole transcriptome analysis (WTA) with random priming and extension (RPE). The RPE-based WTA method can comprise hybridizing random primers with a plurality of first strand barcoded polynucleotides associated with a solid support and extending the random primers to generate a plurality of extension products. The method can comprise amplifying the plurality of extension products to generate a sequencing library.

    APTAMER BARCODING
    48.
    发明申请
    APTAMER BARCODING 审中-公开

    公开(公告)号:US20200058371A1

    公开(公告)日:2020-02-20

    申请号:US16540971

    申请日:2019-08-14

    Abstract: Disclosed herein include systems, methods, compositions, and kits for sample identification and protein expression profiling. A sample indexing composition, or a composition for protein expression profiling, can comprise, for example, a protein binding aptamer associated with an oligonucleotide, such as a sample indexing oligonucleotide. Different oligonucleotides can have different sequences. Sample origin of cells, or protein expression profiles of cells, can be determined based on the sequences of the oligonucleotides by, for example, barcoding the oligonucleotides.

    IMMUNE RECEPTOR-BARCODE ERROR CORRECTION
    50.
    发明申请

    公开(公告)号:US20190095578A1

    公开(公告)日:2019-03-28

    申请号:US16139699

    申请日:2018-09-24

    Abstract: Disclosed herein are methods and systems for determining occurrences of targets. In some embodiments, the method comprises: collapsing putative sequences of the target; collapsing molecular label sequences associated with the putative sequences of the target; and estimating the occurrence of the target, wherein the occurrence of the target estimated correlates with the occurrence of molecular label sequences associated with the putative sequences of the target in the sequencing data after collapsing the occurrence of the putative sequences of the target and the occurrence of noise molecular label sequences.

Patent Agency Ranking